What is Rapport Therapeutics, Inc. Common Stock's Market Cap?

Rapport Therapeutics, Inc. Common Stock's Market Cap is $2.2B, based on as-reported figures from SEC (XBRL) filings.

What is Rapport Therapeutics, Inc. Common Stock's Enterprise Value?

Rapport Therapeutics, Inc. Common Stock's Enterprise Value is $1.8B, based on as-reported figures from SEC (XBRL) filings.

What is Rapport Therapeutics, Inc. Common Stock's EV / EBITDA?

Rapport Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Rapport Therapeutics, Inc. Common Stock's Net Income (TTM)?

Rapport Therapeutics, Inc. Common Stock's Net Income (TTM) is -$137.2M, based on as-reported figures from SEC (XBRL) filings.

What is Rapport Therapeutics, Inc. Common Stock's EBITDA?

Rapport Therapeutics, Inc. Common Stock's EBITDA is -$152.6M, based on as-reported figures from SEC (XBRL) filings.

What is Rapport Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Rapport Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -2.86, based on as-reported figures from SEC (XBRL) filings.

What is Rapport Therapeutics, Inc. Common Stock's Net Debt?

Rapport Therapeutics, Inc. Common Stock's Net Debt is -$436.1M, based on as-reported figures from SEC (XBRL) filings.

Rapport Therapeutics, Inc. Common Stock (RAPP) Financial Statements

Rapport Therapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG01FRNQ4V4

XNAS · usd

46.09▲ 0.32 (0.70%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close45.77

Day's Range44.67 – 47.00

52-Week Range22.06 – 52.93

Volume488.9K

Avg Volume286.9K

Share Statistics

Shares Outstanding

Employees84

ExchangeXNAS

Listed2024-06-07

Share count as of August 3, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Rapport Therapeutics, Inc. Common Stock (RAPP)

What is Rapport Therapeutics, Inc. Common Stock's Market Cap?: Rapport Therapeutics, Inc. Common Stock's Market Cap is $2.2B, based on as-reported figures from SEC (XBRL) filings.
What is Rapport Therapeutics, Inc. Common Stock's Enterprise Value?: Rapport Therapeutics, Inc. Common Stock's Enterprise Value is $1.8B, based on as-reported figures from SEC (XBRL) filings.
What is Rapport Therapeutics, Inc. Common Stock's EV / EBITDA?: Rapport Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Rapport Therapeutics, Inc. Common Stock's Net Income (TTM)?: Rapport Therapeutics, Inc. Common Stock's Net Income (TTM) is -$137.2M, based on as-reported figures from SEC (XBRL) filings.
What is Rapport Therapeutics, Inc. Common Stock's EBITDA?: Rapport Therapeutics, Inc. Common Stock's EBITDA is -$152.6M, based on as-reported figures from SEC (XBRL) filings.
What is Rapport Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Rapport Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -2.86, based on as-reported figures from SEC (XBRL) filings.
What is Rapport Therapeutics, Inc. Common Stock's Net Debt?: Rapport Therapeutics, Inc. Common Stock's Net Debt is -$436.1M, based on as-reported figures from SEC (XBRL) filings.